Your session is about to expire
← Back to Search
Moderate Risk Group for Osteoarthritis
N/A
Waitlist Available
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients must be male or female of any race.
Patients much be age greater than 18 years old.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up optimization time period covers a total time period of 6 months.
Awards & highlights
Study Summary
This trial is testing a new scoring system to predict complications in hip and knee replacement surgery. The goal is to help patients and surgeons make decisions about surgery.
Eligible Conditions
- Osteoarthritis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ optimization time period covers a total time period of 6 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~optimization time period covers a total time period of 6 months.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Optimized Risk Factors
Trial Design
4Treatment groups
Active Control
Group I: Mild Risk GroupActive Control1 Intervention
Group II: Moderate Risk GroupActive Control1 Intervention
Group III: High Risk GroupActive Control1 Intervention
Group IV: Low Risk GroupActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
421 Previous Clinical Trials
163,231 Total Patients Enrolled
25 Trials studying Osteoarthritis
3,238 Patients Enrolled for Osteoarthritis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger